Nifedipine Tablet, Film Coated, Extended Release
Product Images NDC 50742-262

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 50742-262). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

01 (Image 01)

Chemical structure diagram of nifedipine, the active ingredient in the Nifedipine extended-release tablets. The structure shows a dihydropyridine ring with various substituents including nitro and methoxycarbonyl groups attached to the aromatic rings.*

FDA Label Image

02 (Image 02)

A data table comparing the adverse effect percentages in patients taking Nifedipine extended-release tablets versus a placebo. Effects listed include headache, fatigue, dizziness, constipation, and nausea with respective percentages for Nifedipine (N=707) and placebo (N=266).*

FDA Label Image

03 (Image 03)

A data table listing adverse effects reported for Nifedipine capsules versus placebo, showing the percentage of subjects experiencing each effect in two groups of approximately 226 and 235 subjects. Effects include dizziness, flushing, headache, weakness, nausea, muscle cramps, peripheral edema, nervousness, palpitations, dyspnea, and nasal congestion.*

FDA Label Image

04 (Image 04)

FDA Label Image

05 (Image 05)

Label for Nifedipine Extended-Release Tablets USP 30 mg by Ingenus Pharmaceuticals, LLC. It indicates film-coated tablets in a bottle of 100 count. The label includes storage instructions, dosage form, strength, and warnings about moisture protection and proper swallowing. Distributed by Ingenus Pharmaceuticals, Orlando, FL.*

FDA Label Image

06 (Image 06)

Label for Nifedipine Extended-Release Tablets 60 mg by Ingenus Pharmaceuticals, LLC. This oral film-coated tablet is for prescription use only. The label includes dosage form, strength, tablet image marked '60,' and packaging details indicating 100 tablets per container. Storage and safety instructions are also present.*

FDA Label Image

07 (Image 07)

Label for Nifedipine Extended-Release Tablets, USP 90 mg by Ingenus Pharmaceuticals, LLC. The label shows a brown tablet with "90" imprinted, package count of 100 tablets, NDC 50742-262-01, and includes storage, handling, and pharmacist instructions along with barcode and lot/expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.